Phase 3 Readout~month
Phase 3 Topline: A Randomized, Double-masked, Sham-controlled, Multicenter, Phase 3 Study to Evaluate the Efficacy an
- Company
- Kodiak Sciences Inc. (KOD)
- Drug
- macular
- Indication
- Macular Edema Secondary to Inflammation
Other upcoming events for KOD
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.